Filing Details
- Accession Number:
- 0001209191-19-011994
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-21 16:22:52
- Reporting Period:
- 2019-02-19
- Accepted Time:
- 2019-02-21 16:22:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1735944 | Reshma Kewalramani | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Evp And Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-02-19 | 1,186 | $186.75 | 14,038 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-19 | 202 | $187.27 | 13,836 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-02-19 | 100 | $188.49 | 13,736 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Dr. Kewalramani's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $186.75 (range $186.10 to $187.05).
- Dr. Kewalramani undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $187.27 (range $187.11 to $187.49).
- Open market sales reported on this line occurred at a weighted average price of $188.49 (range $188.36 to $188.70).
Billionaire Hedge Funds
